SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cadila Healthcare reports 55.30% rise in Q4 net profit

10 May 2012 Evaluate

Cadila Healthcare has reported results for fourth quarter ended March 31, 2012.

The company has posted a rise of 55.30% in its net profit at Rs 139.40 crore for the quarter ended March 31, 2012 as compared to Rs 89.76 crore for the same quarter in the previous year. Total income has increased by 13.95% at Rs 795.86 crore for quarter under review as compared Rs 698.41 crore for the quarter ended March 31, 2011.

On the consolidated basis, the company has posted a fall of 4.52% in its net profit at Rs 170.88 crore for the quarter ended March 31, 2012 as compared to Rs 178.97 crore for the same quarter in the previous year.    However, total income has increased by 16.34% at Rs 1415.58 crore for quarter under review as compared to Rs 1216.76 crore for the quarter ended March 31, 2011.

For the full year ended March 31, 2012, the company has posted a rise of 7.72% in its net profit at Rs 657.52 crore for the year ended March 31, 2012 as compared to Rs 610.38 crore for the same period in the previous year.  Total income has increased by 13.82% at Rs 3389.92 crore for year under review as compared to Rs 2978.41 crore for the period ended March 31, 2011.

On the consolidated basis, the company has posted a fall of 8.22% in its net profit at Rs 652.59 crore for the year ended March 31, 2012 as compared to Rs 711.00 crore for the same period in the previous year. However, total income has increased by 14.49% at Rs 5316.46 crore for year under review as compared to Rs 4643.70 crore for the period ended March 31, 2011.

Zydus Lifesciences Share Price

939.20 3.20 (0.34%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×